ROSENWALD LINDSAY A MD 4
4 · Fortress Biotech, Inc. · Filed Jul 11, 2024
Insider Transaction Report
Form 4
ROSENWALD LINDSAY A MD
Director
Transactions
- Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-09$7.39/sh+5,000$36,971→ 122,500 total
Footnotes (1)
- [F1]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 9, 2024 was $7.25 to $7.48. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.